Çakan, Zeliha Kübra2024-10-222024-10-222023-08-220172-8172https://doi.org/10.1007/s00296-023-05416-0https://hdl.handle.net/11452/46850The objectives are to describe the demographic and clinical properties of Behcet's disease (BD) and investigate their relationship with the use of biological agents. Four hundred-eighty-eight patients, (299 (61.3%) males, 189 (38.7%) females), who fulfilled the ISG classification criteria for BD were included, retrospectively. The patient's demographics, disease onset age (DOA), clinical findings of the disease, and the drugs were determined and analyzed statistically. The means of patient age and DOA were 40.7 & PLUSMN; 9.9 and 30.8 & PLUSMN; 8.8 years, respectively. The most common initial findings were oral ulcer (OU)s (30.1%), genital ulcer (GU) (27.5%), ocular involvement (OI) (12.5%), and papulopustular lesion (PPL)s (10.1%). The most common clinical manifestations were OUs (96.9%), PPLs (70.2%), HLA-B51 (64.4%), positive pathergy reaction (26.4%), GU (58.8%), OI (44.7%), erythema nodosum (29.8%), and vascular involvement (VSI) (27.3%). Although, the frequency of GU was higher in females (p = 0.01), PPLs (p = 0.001) and VSI (p = 0.001) were higher in males. Sixty-three (8.9%) patients used a biological agent. Its frequency was higher in younger patients (< 40 years) (p = 0.006), males (p = 0.012) and patients with OI (p = 0.001). Besides, the DOA (p = 0.012) and the current age (p = 0.001) were lower in biological agent users. The possibility of using biological agent was increased in males (OR = 2.2), patients with OI (OR = 2.7) and young patients (OR = 0.9). Mucocutaneous lesions are distinctive features of BD, especially OUs precede other findings. GU was more common in females and PPLs and VSI were in males. The probability of using biologics is higher in males, patients with OI, and young patients.eninfo:eu-repo/semantics/closedAccessBehcet diseaseBehcet syndrome*EpidemiologyTherapyGenderPrognosisRetrospective studiesScience & technologyLife sciences & biomedicineRheumatologyClinical features of behcet's disease and prediction of the use of biologics in 488 cases: A single tertiary center studyArticle00105146200000120892097431110.1007/s00296-023-05416-0